NuCycle Appoints New CEO

October 1, 2000

1 Min Read
NuCycle Appoints New CEO


NuCycle Appoints New CEO

MONMOUTH JUNCTION, N.J.--NuCycle Therapy Inc. appointed John Benemann, Ph.D., as president and chief executive officer, taking over for Burt Ensley, who will continue to work with NuCycle in technology development and intellectual property matters. Prior to starting his position at NuCycle on Aug. 1, Benemann worked as an independent consultant at the University of California.

In related news, NuCycle has just received a patent for its line of nutritional supplements. The line includes PhytoSel, PhytoChrom, MultiMins, PhytoZinc and PhytoIron. The latter two products will be available in the next three to five months, according to Benemann. For more information, call (925) 939-5864 or visit Booth #1929 at SupplySide West.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like